Fenazinel Dihydrochloride, also known as SIPI-5052, is a N-methyl-D-aspartate (NMDA) receptor antagonist potentially for the treatment of ischemic stroke.
Uses
Fenazinel dihydrochloride, an N-methyl-D-aspartate (NMDA) receptor antagonist, shows promise as a potential treatment for ischemic stroke.
